Daniel Bohrer

principal financial officer and principal accounting officer, Co-Diagnostics, Inc.

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Daniel Bohrer has been principal financial officer and principal accounting officer of Co-Diagnostics, Inc. since September 2, 2026, according to the company's filing of September 4, 2026.¹

The filing gives Daniel Bohrer's previous role as Executive Vice President of Finance and Accounting at Co-Diagnostics, Inc.¹ Daniel Bohrer already worked at Co-Diagnostics, Inc. when appointed, so the record counts the move as an internal promotion.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Co-Diagnostics, Inc. (CODX) Surgical & Medical Instruments & Apparatus	principal financial officer and principal accounting officer	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

September 2, 2026effective
Co-Diagnostics, Inc. appointed Daniel Bohrer as principal financial officer and principal accounting officer, effective September 2, 2026. Profile of Brian Brown.
Effective as of the Separation Date, Daniel Bohrer, the Company’s Executive Vice President of Finance and Accounting, will serve as the Company’s principal financial officer and principal accounting officer.
[1] Filing by Co-Diagnostics, Inc., filed with the SEC on September 4, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, Co-Diagnostics, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed September 4, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Daniel Bohrer wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.